The diabetes drug metformin — commonly a first choice for controlling blood sugar in people with type 2 diabetes — is sparking new interest as a cancer fighter.
The diabetes drug metformin — commonly a first choice for controlling blood sugar in people with type 2 diabetes — is sparking new interest as a cancer fighter.